Publikationer 2012 2019

Filter
Artikel
2019

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor

Fontana, F., Fusciello, M., Groeneveldt, C., Capasso, C., Chiaro, J., Feola, S., Liu, Z., Mäkilä, E., Salonen, J., Hirvonen, J., Cerullo, V. & Santos, H. A., jun 2019, I : ACS Nano. 13, 6, s. 6477-6490 14 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice

Garofalo, M., Villa, A., Rizzi, N., Kuryk, L., Rinner, B., Cerullo, V., Yliperttula, M., Mazzaferro, V. & Ciana, P., 28 jan 2019, I : Journal of Controlled Release. 294, s. 165-175 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice

Leggiero, E., Labruna, G., Iaffaldano, L., Lombardo, B., Greco, A., Fiorenza, D., Gramanzini, M., Montanaro, D., Baldi, A., Cerullo, V., Sacchetti, L. & Pastore, L., apr 2019, I : Gene Therapy (Basingstoke). 26, 3-4, s. 121-130 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site

Lopes, A., Feola, S., Ligot, S., Fusciello, M., Vandermeulen, G., Préat, V. & Cerullo, V., 10 jul 2019, I : Journal for Immunotherapy of Cancer. 7, 1

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks

Kuryk, L., Moller, A-S. W., Vuolanto, A., Pesonen, S., Garofalo, M., Cerullo, V. & Jaderberg, M., 1 feb 2019, I : International Journal of Molecular Sciences. 20, 3, 15 s., 621.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2018

Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment

Garofalo, M., Saari, H., Somersalo, P., Crescenti, D., Kuryk, L., Aksela, L., Capasso, C., Madetoja, M., Koskinen, K., Oksanen, T., Mäkitie, A., Jalasvuori, M., Cerullo, V., Ciana, P. & Yliperttula, M., 1 jun 2018, I : Journal of Controlled Release. 283, s. 223-234 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model

Kuryk, L., Moller, A-S. W., Garofalo, M., Cerullo, V., Pesonen, S., Alemany, R. & Jaderberg, M., okt 2018, I : Journal of Medical Virology. 90, 10, s. 1669-1673 5 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

Feola, S., Capasso, C., Fusciello, M., Martins, B., Tähtinen, S., Medeot, M., Carpi, S., Frascaro, F., Ylösmaki, E., Peltonen, K., Pastore, L. & Cerullo, V., 2018, I : OncoImmunology. 7, 8, 10 s., 1457596.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

Ylösmäki, E., Malorzo, C., Capasso, C., Honkasalo, O., Fusciello, M., Martins, B., Ylösmäki, L., Louna, A., Feola, S., Paavilainen, H., Peltonen, K., Hukkanen, V., Viitala, T. & Cerullo, V., 5 sep 2018, I : Molecular therapy. 26, 9, s. 2315-2325 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Small-Molecule Targeting of RNA Polymerase I Activates a Conserved Transcription Elongation Checkpoint

Wei, T., Najmi, S. M., Liu, H., Peltonen, K., Kucerova, A., Schneider, D. A. & Laiho, M., 10 apr 2018, I : Cell Reports. 23, 2, s. 404-414 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

The microenvironment of proliferative diabetic retinopathy supports lymphatic neovascularization

Gucciardo, E., Loukovaara, S., Korhonen, A., Repo, P., Martins, B., Vihinen, H., Jokitalo, E. & Lehti, K., jun 2018, I : Journal of Pathology. 245, 2, s. 172-185 14 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2017

ANKRD54 preferentially selects Bruton's Tyrosine Kinase (BTK) from a Human Src-Homology 3 (SH3) domain library

Gustafsson, M. O., Mohammad, D. K., Ylosmaki, E., Choi, H., Shrestha, S., Wang, Q., Nore, B. F., Saksela, K. & Smith, C. I. E., 3 apr 2017, I : PLoS One. 12, 4, 13 s., 0174909.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma

Capasso, C., Magarkar, A., Cervera-Carascon, V., Fusciello, M., Feolaf, S., Muller, M., Garofalo, M., Kuryk, L., Tahtinen, S., Pastore, L., Bunker, A. & Cerullo, V., 2017, I : OncoImmunology. 6, 9, 14 s., 1319028.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles

Lazaro Ibañez, E., Neuvonen, K. M., Takatalo-Laine, S. M., Thanigai Arasu, U., Capasso, C., Cerullo, V., Rhim, J., Rilla, K., Yliperttula, M. L. & Siljander, P. R-M., 10 aug 2017, I : Journal of Extracellular Vesicles.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Severe neurodegenerative disease in brothers with homozygous mutation in POLR1A

Kara, B., Koroglu, C., Peltonen, K., Steinberg, R. C., Genc, H. M., Holtta-Vuori, M., Guven, A., Kanerva, K., Kotil, T., Solakoglu, S., Zhou, Y., Olkkonen, V. M., Ikonen, E., Laiho, M. & Tolun, A., feb 2017, I : European Journal of Human Genetics. 25, 3, s. 315-323 9 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång

Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102-Support for clinical studies on advanced cancer treatment

Kuryk, L., Vassilev, L., Ranki, T., Hemminki, A., Karioja-Kallio, A., Levälampi, O., Vuolanto, A., Cerullo, V. & Pesonen, S., 10 aug 2017, I : PLoS One. 12, 8, 15 s., 0182715.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2016

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

Taipale, K., Liikanen, I., Juhila, J., Turkki, R., Tahtinen, S., Kankainen, M., Vassilev, L., Ristimaki, A., Koski, A., Kanerva, A., Diaconu, I., Cerullo, V., Vaha-Koskela, M., Oksanen, M., Linder, N., Joensuu, T., Lundin, J. & Hemminki, A., jan 2016, I : Molecular therapy. 24, 1, s. 175-183 9 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity

Hirvinen, M., Capasso, C., Guse, K., Garofalo, M., Vitale, A., Ahonen, M., Kuryk, L., Vähä-Koskela, M., Hemminki, A., Fortino, V., Greco, D. & Cerullo, V., 23 mar 2016, I : Molecular Therapy - Oncolytics. 3, 9 s., 16002.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic Replication

Balistreri, G., Viiliainen, J., Turunen, M., Diaz, R., Lyly, L., Pekkonen, P., Rantala, J., Ojala, K., Sarek, G., Teesalu, M., Denisova, O., Peltonen, K., Julkunen, I., Varjosalo, M., Kainov, D., Kallioniemi, O., Laiho, M., Taipale, J., Hautaniemi, S. & Ojala, P. M., feb 2016, I : PLoS Pathogens. 12, 2, 26 s., 1005424.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the anti-tumor immunity and efficacy against melanoma

Capasso, C., Hirvinen, M., Garofalo, M., Romaniuk, D., Kuryk, L., Sarvela, T., Vitale, A., Antopolsky, M., Magarkar, A., Viitala, T., Suutari, T., Bunker, A., Yliperttula, M., Urtti, A. & Cerullo, V., 2016, I : OncoImmunology. 5, 4, 11 s., 1105429.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity

Garofalo, M., Iovine, B., Kuryk, L., Capasso, C., Hirvinen, M., Vitale, A., Yliperttula, M., Bevilacqua, M. A. & Cerullo, V., apr 2016, I : Molecular Cancer Therapeutics. 15, 4, s. 651-660 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Selective replication of miR-145-regulated oncolytic adenovirus in MCF-7 breast cancer cells

Shayestehpour, M., Moghim, S., Salimi, V., Jalilvand, S., Yavarian, J., Romani, B., Ylosmaki, E. & Mokhtari-Azad, T., okt 2016, I : Future Virology. 11, 10, s. 671-680 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model

Kuryk, L., Haavisto, E., Garofalo, M., Capasso, C., Hirvinen, M., Pesonen, S., Ranki, T., Vassilev, L. & Cerullo, V., 15 okt 2016, I : International Journal of Cancer. 139, 8, s. 1883-1893 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes

Ruan, M. Z. C., Cerullo, V., Cela, R., Clarke, C., Lundgren-Akerlund, E., Barry, M. A. & Lee, B. H. L., 2016, I : Molecular therapy-Methods & clinical development. 3, 8 s., 16008.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2015

GMCSF-armed vaccinia virus induces an antitumor immune response

Parviainen, S., Ahonen, M., Diaconu, I., Kipar, A., Siurala, M., Vaha-Koskela, M., Kanerva, A., Cerullo, V. & Hemminki, A., 1 mar 2015, I : International Journal of Cancer. 136, 5, s. 1065-1072 8 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Immunological Effects of a Tumor Necrosis Factor Alpha-Armed Oncolytic Adenovirus

Hirvinen, M., Rajecki, M., Kapanen, M., Parviainen, S., Rouvinen-Lagerstrom, N., Diaconu, I., Nokisalmi, P., Tenhunen, M., Hemminki, A. & Cerullo, V., 1 mar 2015, I : Human Gene Therapy. 26, 3, s. 134-144 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma

Siurala, M., Bramante, S., Vassilev, L., Hirvinen, M., Parviainen, S., Tahtinen, S., Guse, K., Cerullo, V., Kanerva, A., Kipar, A., Vaha-Koskela, M. & Hemminki, A., 15 feb 2015, I : International Journal of Cancer. 136, 4, s. 945-954 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

Vaha-Koskela, M., Tahtinen, S., Gronberg-Vaha-Koskela, S., Taipale, K., Saha, D., Merisalo-Soikkeli, M., Ahonen, M., Rouvinen-Lagerstrom, N., Hirvinen, M., Veckman, V., Matikainen, S., Zhao, F., Pakarinen, P., Salo, J., Kanerva, A., Cerullo, V. & Hemminki, A., 7 jan 2015, I : Molecular Therapy - Oncolytics. 2, 9 s., 14006.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Synthesis and Evaluation of the Antiproliferative Properties of a Tethered Tubercidin-Platinum(II) Complex

D'Errico, S., Oliviero, G., Borbone, N., Di Gennaro, E., Zotti, A. I., Budillon, A., Cerullo, V., Nici, F., Mayol, L., Piccialli, V. & Piccialli, G., dec 2015, I : European Journal of Organic Chemistry. 34, s. 7550-7556 7 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

Bramante, S., Kaufmann, J. K., Veckman, V., Liikanen, I., Nettelbeck, D. M., Hemminki, O., Vassilev, L., Cerullo, V., Oksanen, M., Heiskanen, R., Joensuu, T., Kanerva, A., Pesonen, S., Matikainen, S., Vaha-Koskela, M., Koski, A. & Hemminki, A., 1 okt 2015, I : International Journal of Cancer. 137, 7, s. 1775-1783 9 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2014

Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors

Nishio, N., Diaconu, I., Liu, H., Cerullo, V., Caruana, I., Hoyos, V., Bouchier-Hayes, L., Savoldo, B. & Dotti, G., 15 sep 2014, I : Cancer Research. 74, 18, s. 5195-5205 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging

Parviainen, S., Ahonen, M., Diaconu, I., Hirvinen, M., Karttunen, A., Vähä-Koskela, M., Hemminki, A. & Cerullo, V., feb 2014, I : Gene Therapy (Basingstoke). 21, 2, s. 195-204 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy

Farzad, L., Cerullo, V., Yagyu, S., Bertin, T., Hemminki, A., Rooney, C., Lee, B. & Suzuki, M., 2014, I : Molecular Therapy - Oncolytics. 1, 9 s., 14008.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders

Hemminki, O., Immonen, R., Narvainen, J., Kipar, A., Paasonen, J., Jokivarsi, K. T., Yli-Ollila, H., Soininen, P., Partanen, K., Joensuu, T., Parvianen, S., Koski, A., Vähä-Koskela, M., Cerullo, V., Pesonen, S., Grohn, O. H. & Hemminki, A., 15 jun 2014, I : International Journal of Cancer. 134, 12, s. 2878-2890 13 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

Bramante, S., Koski, A., Kipar, A., Diaconu, I., Liikanen, I., Hemminki, O., Vassilev, L., Parviainen, S., Cerullo, V., Pesonen, S. K., Oksanen, M., Heiskanen, R., Rouvinen-Lagerstroem, N., Merisalo-Soikkeli, M., Hakonen, T., Joensuu, T., Kanerva, A-M., Pesonen, S. & Hemminki, A., 1 aug 2014, I : International Journal of Cancer. 135, 3, s. 720-730 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications

Capasso, C., Garofalo, M., Hirvinen, M. & Cerullo, V., feb 2014, I : Viruses. 6, 2, s. 832-855 24 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil
2013

Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus

Kanerva, A., Nokisalmi, P., Diaconu, I., Koski, A., Cerullo, V., Liikanen, I., Tahtinen, S., Oksanen, M., Heiskanen, R., Pesonen, S., Joensuu, T., Alanko, T., Partanen, K., Laasonen, L., Kairemo, K., Pesonen, S., Kangasniemi, L. & Hemminki, A., 15 maj 2013, I : Clinical Cancer Research. 19, 10, s. 2734-2744 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral Vectors

Capasso, C., Hirvinen, M. & Cerullo, V., 4 dec 2013, I : Biomedicines. 1, 1, s. 3-16 14 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

Hirvinen, M., Heiskanen, R., Oksanen, M., Pesonen, S., Liikanen, I., Joensuu, T., Kanerva, A., Cerullo, V. & Hemminki, A., 21 aug 2013, I : Journal of Translational Medicine. 11, Article Number: 193, 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

Genetic diversity and tumor immunesurveillance

Hirvinen, M. & Cerullo, V., feb 2013, I : Journal of thoracic disease. 5, 1, s. 6-7 2 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients

Liikanen, I., Ahtiainen, L., Hirvinen, M. L. M., Bramante, S., Cerullo, V., Nokisalmi, P., Hemminki, O., Diaconu, I., Pesonen, S., Koski, A., Kangasniemi, L., Pesonen, S. K., Oksanen, M., Laasonen, L., Partanen, K., Joensuu, T., Zhao, F., Kanerva, A. & Hemminki, A., jun 2013, I : Molecular therapy. 21, 6, s. 1212-1223 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Öppen tillgång
Fil

PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice

Leggiero, E., Astone, D., Cerullo, V., Lombardo, B., Mazzaccara, C., Labruna, G., Sacchetti, L., Salvatore, F., Croyle, M. & Pastore, L., 2013, I : Gene Therapy (Basingstoke). 20, 12, s. 1124-1130 7 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

2012

Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer

Hemminki, O., Diaconu, I., Cerullo, V., Pesonen, S. K., Kanerva, A-M., Joensuu, T., Kairemo, K., Laasonen, L., Partanen, K., Kangasniemi, L., Lieber, A., Pesonen, S. & Hemminki, A., 1 sep 2012, I : Molecular therapy. 20, 9, s. 1821-1830 10 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance

Cerullo, V., Diaconu, I., Romano, V., Hirvinen, M., Ugolini, M., Escutenaire, S., Sirkka-Liisa, H., Kipar, A., Kanerva, A-M. & Hemminki, A., 1 nov 2012, I : Molecular therapy. 20, 11, s. 2076-2086 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Capsid-Modified Adenoviral Vectors for Improved Muscle-Directed Gene Therapy

Guse, K., Suzuki, M., Sule, G., Bertin, T. K., Tyynismaa, H., Ahola-Erkkila, S., Palmer, D., Suomalainen, A., Ng, P., Cerullo, V., Hemminki, A. & Lee, B., 1 okt 2012, I : Human Gene Therapy. 23, 10, s. 1065-1070 6 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer

Kangasniemi, L., Parviainen, S., Pisto, T., Koskinen, M., Jokinen, M., Kiviluoto, T., Cerullo, V., Jalonen, H., Koski-Palkén, A., Kangasniemi, A., Kanerva, A., Pesonen, S. & Hemminki, A. E., 2012, I : International Journal of Cancer. 131, 1, s. 253-263 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus

Diaconu, I., Cerullo, V., Hirvinen, M. L. M., Escutenaire, S., Ugolini, M., Pesonen, S. K., Bramante, S., Parviainen, S., Kanerva, A-M., Loskog, A. S. I., Eliopoulos, A. G., Pesonen, S. & Hemminki, A., 2012, I : Cancer Research. 72, 9, s. 2327-2338 12 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.

Pesonen, S., Diaconu, I., Cerullo, V., Escutenaire, S., Raki, M., Kangasniemi, L., Nokisalmi, P., Dotti, G., Guse, K., Laasonen, L., Partanen, K., Karli, E., Haavisto, E., Oksanen, M. K., Karioja-Kallio, A., Hannuksela, P., Sirkka-Liisa, H., Kauppinen, S., Joensuu, T. K., Kanerva, A. & 1 andraHemminki, A. E., 2012, I : International Journal of Cancer. 130, 8, s. 1937-1947 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Oncolytic adenoviruses A potent form of tumor immunovirotherapy

Cerullo, V., Vähä-Koskela, M. & Hemminki, A., sep 2012, I : OncoImmunology. 1, 6, s. 979-981 3 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients

Pesonen, S., Diaconu, I., Kangasniemi, L., Ranki, T., Kanerva, A-M., Pesonen, S. K., Gerdemann, U., Leen, A. M., Kairemo, K., Oksanen, M., Haavisto, E., Sirkka-Liisa, H., Karioja-Kallio, A., Kauppinen, S., Partanen, K. P. L., Laasonen, L., Joensuu, T., Alanko, T., Cerullo, V. & Hemminki, A., 2012, I : Cancer Research. 72, 7, s. 1621-1631 11 s.

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review